Applied Clinical Trials Direct
Having trouble viewing this e-mail? Click here.
  February 26, 2013
In This Edition
News Roundup: Quintiles Files for IPO
Blog Posts: New Approval Pathway for Small Clinical Trials
Marketplace: Marketplace

News Roundup
bullet Quintiles Files for IPO
The number of shares to be offered by the current largest private CRO have not yet been determined
bullet Mixed Year Ahead for Big Pharma
Pharmaceutical Executive magazine’s annual survey of trends and issues facing the biopharma is based on interviews with more than 20 top opinion leaders and experts
bullet Take This CTMS Survey
Provide your input around how CTMS is being used and will evolve over the next two years
bullet Does FDA Lack Comprehensive REMS Data?
OIG report says yes based on its reviews of approved REMS since the program's inception in 2008 through 2011

Blogs Posts
bullet New Approval Pathway for Small Clinical Trials
Limited Population Antibacterial Drug approval mechanism proposed by the Infectious Diseases Society of America, would permit FDA approval of a drug for a very narrow indication based on smaller, faster clinical trials for targeted patient populations
bullet Oncology Clinical Trials: Patients on the Edge of Hope and Science
Listen to Linda Strause, PhD, Executive Director and Head, Clinical Operations Vical Inc., discuss her professional and personal journey with cancer trials

Webcasts & Events
bullet ClinTech 2013--eTMF, CTMS, Portals, EDC
bullet The Why and How of Social Media for Clinical Trial Professionals

Marketplace

Sponsored
ArisGlobal
Are resource & capacity planning issues causing costly trial delays? Free white paper to learn how CTMS planning tools can make all the difference.
Click Here

Follow Us

Ask The Editor

Lisa Henderson
Editor in Chief [email protected]